Due for re-check: the scheduled review date of 2026-09-13 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
0143-9933-25 · Cefotaxime Sodium Powder, for Solution · Hikma Pharmaceuticals USA, Inc.
What is the package ndc for 0143-9933-25 · Cefotaxime Sodium Powder, for Solution · Hikma Pharmaceuticals USA, Inc.?
For 0143-9933-25 · Cefotaxime Sodium Powder, for Solution · Hikma Pharmaceuticals USA, Inc., package ndc is 0143-9933-25; generic name is Cefotaxime Sodium Powder, for Solution; manufacturer is Hikma Pharmaceuticals USA, Inc; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01; source re-checked 2026-09-10.
"initial_posting_date": "02/17/2015", "package_ndc": "0143-9933-25", "generic_name": "Cefotaxime Sodium Powder, for Solution", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 0143-9933-25 verified
- Generic name
- Cefotaxime Sodium Powder, for Solution verified
- Manufacturer
- Hikma Pharmaceuticals USA, Inc. verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Estimated recovery: TBD verified
- Initial posting date
- 02/17/2015 verified
- Last update date
- 08/13/2026 verified
- Days in shortage
- 4214 our reading
- Reason for shortage
- Demand increase for the drug verified
- Dosage form
- Powder, For Solution verified
- Therapeutic category
- Anti-Infective verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/13/2026", "therapeutic_category": [ "Anti-Infective", "Pediatric" ], "dosage_form": "Powder, For Solution", "presentation": "Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000